Cargando…

Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?

PURPOSE OF REVIEW: To summarize the mechanisms of tumor angiogenesis and resistance to antiangiogenic therapy, and the influence on tumor microenvironment. RECENT FINDINGS: Several clinical trials have investigated the activity of anti-VEGF monoclonal antibodies and tyrosine kinase inhibitors in gli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pellerino, Alessia, Bruno, Francesco, Soffietti, Riccardo, Rudà, Roberta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256654/ https://www.ncbi.nlm.nih.gov/pubmed/37071295 http://dx.doi.org/10.1007/s11912-023-01417-1

Ejemplares similares

Targeted Therapies in Rare Brain Tumours
por: Bruno, Francesco, et al.
Publicado: (2021)

Neurotoxicity from Old and New Radiation Treatments for Brain Tumors
por: Soffietti, Riccardo, et al.
Publicado: (2023)

Blood–Brain Barrier in Brain Tumors: Biology and Clinical Relevance
por: Mo, Francesca, et al.
Publicado: (2021)

Ependymoma: Evaluation and Management Updates
por: Rudà, Roberta, et al.
Publicado: (2022)

Neoplastic meningitis in solid tumors: from diagnosis to personalized treatments
por: Pellerino, Alessia, et al.
Publicado: (2018)

Leptomeningeal Metastases from Solid Tumors: Recent Advances in Diagnosis and Molecular Approaches
por: Pellerino, Alessia, et al.
Publicado: (2021)

Clinical Significance of Molecular Alterations and Systemic Therapy for Meningiomas: Where Do We Stand?
por: Pellerino, Alessia, et al.
Publicado: (2022)

Management of Brain and Leptomeningeal Metastases from Breast Cancer
por: Pellerino, Alessia, et al.
Publicado: (2020)

BSBM-12 STAT3 EXPRESSION IN BRAIN METASTASES FROM BREAST CANCER: CORRELATIONS WITH DIFFERENT MOLECULAR SUBTYPES AND CLINICAL OUTCOME
por: Pellerino, Alessia, et al.
Publicado: (2023)

Neratinib and Capecitabine for the Treatment of Leptomeningeal Metastases from HER2-Positive Breast Cancer: A Series in the Setting of a Compassionate Program
por: Pellerino, Alessia, et al.
Publicado: (2022)

Glioblastoma in the Elderly: Review of Molecular and Therapeutic Aspects
por: Bruno, Francesco, et al.
Publicado: (2022)

Pembrolizumab-Induced Isolated Cranial Neuropathy: A Rare Case Report and Review of Literature
por: Bruno, Francesco, et al.
Publicado: (2021)

Mechanisms and Therapy for Cancer Metastasis to the Brain
por: Franchino, Federica, et al.
Publicado: (2018)

Brain Metastasis from Unknown Primary Tumour: Moving from Old Retrospective Studies to Clinical Trials on Targeted Agents
por: Balestrino, Roberta, et al.
Publicado: (2020)

Primary CNS Lymphomas: Challenges in Diagnosis and Monitoring
por: Chiavazza, C., et al.
Publicado: (2018)

NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target
por: Gambella, Alessandro, et al.
Publicado: (2020)

Antiangiogenic Therapy and Mechanisms of Tumor Resistance in Malignant Glioma
por: Rahman, Ruman, et al.
Publicado: (2010)

Progress on Antiangiogenic Therapy for Patients with Malignant Glioma
por: Ahluwalia, Manmeet S., et al.
Publicado: (2010)

Antiangiogenic therapies in urogenital malignancies: Fiction or fact?
por: Haidl, Friederike, et al.
Publicado: (2017)

Ganglioside GM3 Is Antiangiogenic in Malignant Brain Cancer
por: Seyfried, Thomas N., et al.
Publicado: (2010)

Prognostic Factors and Current Treatment Strategies for Renal Cell Carcinoma Metastatic to the Brain: An Overview
por: Internò, Valeria, et al.
Publicado: (2021)

Antiangiogenics in Malignant Granular Cell Tumors: Review of the Literature
por: Torrado, Carlos, et al.
Publicado: (2023)

Newly diagnosed Glioblastoma Multiforme (GBM) during COVID-19 pandemic: changes in therapeutic approach to minimize in-hospital SARS-COV-2 contagion in pre-vaccine era
por: Internò, Valeria, et al.
Publicado: (2022)

Elderly Gliobastoma Patients: The Impact of Surgery and Adjuvant Treatments on Survival: A Single Institution Experience
por: Bruno, Francesco, et al.
Publicado: (2022)

Antiangiogenic therapy
por: Avitabile, T
Publicado: (2010)

Antiangiogenic Therapy for Patients with Recurrent and Newly Diagnosed Malignant Gliomas
por: Shirai, Katsuyuki, et al.
Publicado: (2012)

Does science still matter? The evolution of doubts
por: Broad, W J, et al.
Publicado: (2004)

Use of Antiangiogenic Therapies in Pediatric Solid Tumors
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021)

The inefficacy of antiangiogenic therapies
por: Ribatti, Domenico
Publicado: (2010)

Antiangiogenic Therapy for Glioma
por: Cea, Valentina, et al.
Publicado: (2012)

Antiangiogenic Cancer Therapy
por: Maxwell, P H, et al.
Publicado: (2009)

The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment
por: Hu, Haoyue, et al.
Publicado: (2022)

Does Locoregional Chemotherapy Still Matter in the Treatment of Advanced Pelvic Melanoma?
por: Guadagni, Stefano, et al.
Publicado: (2017)

Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
por: Zarrin, Bahare, et al.
Publicado: (2017)

Antiangiogenic therapy for breast cancer
por: Nielsen, Dorte Lisbet, et al.
Publicado: (2010)

Antiangiogenic therapies in ovarian cancer
por: Reinthaller, Alexander
Publicado: (2016)

Antiangiogenic therapy in breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2017)

Antiangiogenic Therapy for Diabetic Nephropathy
por: Tanabe, Katsuyuki, et al.
Publicado: (2017)

Resistance to Antiangiogenic Therapy in Hepatocellular Carcinoma: From Molecular Mechanisms to Clinical Impact
por: Federico, Piera, et al.
Publicado: (2022)

Convection-Enhanced Delivery of Antiangiogenic Drugs and Liposomal Cytotoxic Drugs to Heterogeneous Brain Tumor for Combination Therapy
por: Bhandari, Ajay, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_loep7gsfg9rf3vifgf82bvkruu